126 related articles for article (PubMed ID: 6800808)
21. The effect of captopril on renal, coronary, and systemic hemodynamics in patients with severe congestive heart failure.
Powers ER; Bannerman KS; Stone J; Reison DS; Escala EL; Kalischer A; Weiss MB; Sciacca RR; Cannon PJ
Am Heart J; 1982 Nov; 104(5 Pt 2):1203-10. PubMed ID: 6753550
[TBL] [Abstract][Full Text] [Related]
22. Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects.
Sharpe DN; Coxon R
Aust N Z J Med; 1982 Oct; 12(5):483-8. PubMed ID: 6758746
[TBL] [Abstract][Full Text] [Related]
23. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
Creager MA; Faxon DP; Weiner DA; Ryan TJ
Br Heart J; 1985 Apr; 53(4):431-5. PubMed ID: 3885981
[TBL] [Abstract][Full Text] [Related]
24. Low-dose captopril in chronic heart failure: acute haemodynamic effects and long-term treatment.
Sharpe DN; Douglas JE; Coxon RJ; Long B
Lancet; 1980 Nov; 2(8205):1154-7. PubMed ID: 6107767
[TBL] [Abstract][Full Text] [Related]
25. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
Kluger J; Cody RJ; Laragh JH
Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
[TBL] [Abstract][Full Text] [Related]
26. Improvement of chronic congestive heart-failure by oral captopril.
Turini GA; Brunner HR; Gribic M; Waeber B; Gavras H
Lancet; 1979 Jun; 1(8128):1213-5. PubMed ID: 87679
[TBL] [Abstract][Full Text] [Related]
27. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
[TBL] [Abstract][Full Text] [Related]
28. [Long-term treatment of severe cardiac failure with captopril (author's transl)].
Komajda M; Eugène M; Evans J; Lecossier D; Grosgogeat Y
Nouv Presse Med; 1981 Apr; 10(19):1587-90. PubMed ID: 7025850
[TBL] [Abstract][Full Text] [Related]
29. [Long-term treatment of chronic heart failure by an inhibitor of angiotensin converting enzyme].
Komajda M; Eugène M; Evans J; Laurenceau JL; Hubermann JP; Thomas D; Drobinski G; Leprince JL; Ganty J; Wajman A; Guedj D; Grosgogeat Y
Arch Mal Coeur Vaiss; 1983 Jan; 76(1):29-36. PubMed ID: 6303239
[TBL] [Abstract][Full Text] [Related]
30. Hemodynamic effects of captopril in patients with severe chronic heart failure.
LeJemtel TH; Keung E; Frishman WH; Ribner HS; Sonnenblick EH
Am J Cardiol; 1982 Apr; 49(6):1484-8. PubMed ID: 7041587
[TBL] [Abstract][Full Text] [Related]
31. [Hemodynamic effects of oral captopril in patients with critical aortic stenosis].
Martínez Sánchez C; Henne O; Arceo A; Peña M; González H; Chuquiure E; Lupi E
Arch Inst Cardiol Mex; 1996; 66(4):322-30. PubMed ID: 8984953
[TBL] [Abstract][Full Text] [Related]
32. Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme.
Davis R; Ribner HS; Keung E; Sonnenblick EH; LeJemtel TH
N Engl J Med; 1979 Jul; 301(3):117-21. PubMed ID: 221810
[TBL] [Abstract][Full Text] [Related]
33. Phentolamine for vasodilator therapy in left ventricular failure complicating acute myocardial infarction. Haemodynamic study.
Perret Cl; Gardaz JP; Reynaert M; Grimbert F; Enrico JF
Br Heart J; 1975 Jun; 37(6):640-6. PubMed ID: 1148063
[TBL] [Abstract][Full Text] [Related]
34. Plasma free captopril concentrations during short and long term treatment with oral captopril for heart failure.
Shaw TR; Duncan FM; Williams BC; Crichton E; Thomson SA; Davis JR; Rademaker M; Edwards CR
Br Heart J; 1985 Aug; 54(2):160-5. PubMed ID: 3893490
[TBL] [Abstract][Full Text] [Related]
35. Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs.
Packer M; Medina N; Yushak M
Am Heart J; 1982 Nov; 104(5 Pt 2):1215-23. PubMed ID: 6753552
[TBL] [Abstract][Full Text] [Related]
36. Converting-enzyme inhibitor therapy for chronic heart failure.
Massie BM; Kramer BL; Topic N
Herz; 1983 Apr; 8(2):71-80. PubMed ID: 6343210
[TBL] [Abstract][Full Text] [Related]
37. Haemodynamic and myocardial metabolic effects of captopril in chronic heart failure.
Chatterjee K; Rouleau JL; Parmley WW
Br Heart J; 1982 Mar; 47(3):233-8. PubMed ID: 7037025
[TBL] [Abstract][Full Text] [Related]
38. [Enhancement of the effect of captopril in the 1st 48 hours of treating refractory heart failure. A comparison with intravenous trinitrine].
Le Pailleur C; Baubion N; Metzger JP; Heulin A; Vacheron A; Di Matteo J
Arch Mal Coeur Vaiss; 1984 Jun; 77(6):700-6. PubMed ID: 6431936
[TBL] [Abstract][Full Text] [Related]
39. Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.
Ricci S; Zaniol P; Teglio V; Baraldi P; Mattioli G
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):209S-215S. PubMed ID: 6291564
[TBL] [Abstract][Full Text] [Related]
40. Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure.
Topic N; Kramer B; Massie B
Am Heart J; 1982 Nov; 104(5 Pt 2):1172-9. PubMed ID: 6291362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
